Data as of May 17
| +1.34 / +2.44%|
The 23 analysts offering 12-month price forecasts for Gilead Sciences Inc have a median target of 65.00, with a high estimate of 88.00 and a low estimate of 40.00. The median estimate represents a +15.45% increase from the last price of 56.30.
The current consensus among 28 polled investment analysts is to Buy stock in Gilead Sciences Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.